TOX3 Mutations in Breast Cancer

TOX3 maps to 16q12, a region commonly lost in breast cancers and recently implicated in the risk of developing breast cancer. However, not much is known of the role of TOX3 itself in breast cancer biology. This is the first study to determine the importance of TOX3 mutations in breast cancers. We screened TOX3 for mutations in 133 breast tumours and identified four mutations (three missense, one in-frame deletion of 30 base pairs) in six primary tumours, corresponding to an overall mutation frequency of 4.5%. One potentially deleterious missense mutation in exon 3 (Leu129Phe) was identified in one tumour (genomic DNA and cDNA). Whilst copy number changes of 16q12 are common in breast cancer, our data show that mutations of TOX3 are present at low frequency in tumours. Our results support that TOX3 should be further investigated to elucidate its role in breast cancer biology.

[1]  Liam J. McGuffin,et al.  Protein structure prediction servers at University College London , 2005, Nucleic Acids Res..

[2]  S. Tavaré,et al.  High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer , 2007, Genome Biology.

[3]  Carlos Caldas,et al.  Fine scale mapping of the breast cancer 16q12 locus. , 2010, Human molecular genetics.

[4]  Gabriella Siszler,et al.  TOX3 is a neuronal survival factor that induces transcription depending on the presence of CITED1 or phosphorylated CREB in the transcriptionally active complex , 2011, Journal of Cell Science.

[5]  C. Béroud,et al.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.

[6]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[7]  Mingming Jia,et al.  COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..

[8]  Swneke D. Bailey,et al.  Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression , 2012, Nature Genetics.

[9]  Y. Drouet,et al.  Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypes , 2012, Breast Cancer Research and Treatment.

[10]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[11]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[12]  F. Marincola,et al.  TNRC9 downregulates BRCA1 expression and promotes breast cancer aggressiveness. , 2013, Cancer research.

[13]  B. Agnarsson,et al.  The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714predict adverse outcome for breast cancer patients , 2012, BMC Cancer.

[14]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[15]  I. Ellis,et al.  A gene-expression signature to predict survival in breast cancer across independent data sets , 2007, Oncogene.

[16]  Anirvan Ghosh,et al.  Tox3 Regulates Calcium-dependent Transcription in Neurons We Report the Cloning and Characterization of Tox3, a High Mobility Group Box Protein Involved in Mediating Calcium-dependent Tran- Scription. Tox3 Was Identified as a Calcium-dependent Transactivator Using the Transactivator Trap Screen. We , 2022 .

[17]  B. Ponder,et al.  Extent of differential allelic expression of candidate breast cancer genes is similar in blood and breast , 2009, Breast Cancer Research.

[18]  J. Kaye,et al.  TOX defines a conserved subfamily of HMG-box proteins , 2003, BMC Genomics.

[19]  H. Lehrach,et al.  An efficient and economic enhancer mix for PCR. , 2006, Biochemical and biophysical research communications.

[20]  D. Gudbjartsson,et al.  Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer , 2007, Nature Genetics.